It has been reported that PAI-1 is involved in tumor progression in patients with lung cancer, pleural malignant mesothelioma, breast cancer, esophageal cancer, gastric cancer, and renal cancer [32,33,34,35,36,37,38]. Here, SERPINE1 is linked to breast carcinoma.